MRJF22
prodrug of the sigma ligand haloperidol metabolite II conjugated with the histone deacetylase inhibitor valproic acid
Also Known As:
4-((4-chlorophenyl)-4-hydroxypiperidin-1-yl)-1-(4-fluorophenyl)butyl-2-propylpentanoate
Networked: 1
relevant articles (0 outcomes,
1 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Amata, Emanuele:
1 article
(01/2021)
|
2. | Anfuso, Carmelina Daniela:
1 article
(01/2021)
|
3. | Barbaraci, Carla:
1 article
(01/2021)
|
4. | Cacciatore, Ivana:
1 article
(01/2021)
|
5. | Dichiara, Maria:
1 article
(01/2021)
|
6. | Giurdanella, Giovanni:
1 article
(01/2021)
|
7. | Leotta, Claudia Giovanna:
1 article
(01/2021)
|
8. | Longo, Anna:
1 article
(01/2021)
|
9. | Lupo, Gabriella:
1 article
(01/2021)
|
10. | Marrazzo, Agostino:
1 article
(01/2021)
|
Related Diseases
Related Drugs and Biologics